BTAI — BioXcel Therapeutics, Inc.

BTAIBioXcel Therapeutics, Inc.

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · bioxceltherapeutics.com

1.190USD-0.42%Mkt Cap: 36.74M USDP/E: —Last update: 2026-06-01

BioXcel Therapeutics, Inc., together with its subsidiary, OnkosXcel Therapeutics LLC, operates as a biopharmaceutical company that utilizes artificial intelligence approaches to develop medicines in neuroscience and immu…

Industry Peers

Drug Manufacturers - Specialty & Generic

SOBI

Swedish Orphan Biovitrum AB (publ)

150.78BSEKP/E 166.4

ECILC

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S.

United Therapeutics Corporation

Neurocrine Biosciences, Inc.

Indicators:|

Key Statistics

Company

Market Cap36.74M USD

Enterprise Value119.24M USD

Revenue (TTM)680.00K USD

Gross Profit478.00K USD

Net Income (TTM)-69.90M USD

Revenue/Share0.0400 USD

Last Price1.190 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees29

CountryUS

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISINUS09075P1057

Valuation

P/E (Trailing)—

P/E (Forward)-0.76

PEG—

EV/EBITDA-2.38

EV/Revenue175.35

P/S53.13

P/B-0.30

EPS (TTM)-4.77

EPS (Forward)-1.54

52W Range

1.0103% of range8.080

52W High8.080 USD

52W Low1.010 USD

Profitability

Gross Margin74.45%

Oper. Margin-4962.62%

EBITDA Margin0.00%

Profit Margin-10887.38%

ROE73.22%

ROA-155.62%

Growth

Revenue Growth22.60%

Earnings Growth—

Cash Flow & Leverage

Operating CF-57.62M USD

CapEx (TTM)—

FCF Margin-5017.43%

FCF Yield-92.85%

Net Debt83.11M USD

Net Debt/EBITDA-1.66

Balance Sheet

Debt/Equity-1.15

Current Ratio0.62

Quick Ratio0.32

Book Value/Sh-3.8980 USD

Cash/Share0.5560 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:16

Split DateFeb 10, 2025

Analyst Consensus

Rating1.8 (Buy)

Target (Mean)14.00 USD

Target Range1.000 USD – 38.00 USD

# Analysts4

Ownership

Shares Out.30.88M

Float26.40M

Insiders3.65%

Institutions18.72%

Short Interest

Short Ratio4.5d

Short % Float11.73%

Short % Out.11.51%

Shares Short3.56M

Short (prev mo.)3.95M

Technical

SMA 501.207 (-1.4%)

SMA 2002.079 (-42.8%)

Beta0.31

S&P 52W Chg27.94%

Avg Vol (30d)687.26K

Avg Vol (10d)695.15K

Technical Indicators

RSI (14)49.9

MACD0.0048

MACD Signal-0.0096

MACD Hist.+0.0144

BB Upper1.336 USD

BB Middle1.200 USD

BB Lower1.063 USD

BB Width22.80%

ATR (14)0.0890 USD

Vol Ratio (20d)1.09x